Ophtalmological Characteristics of Patients With Craniosynostosis Followed at the Amiens University Hospital
Launched by CENTRE HOSPITALIER UNIVERSITAIRE, AMIENS · Apr 8, 2025
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the eye-related issues that can occur in patients with craniosynostosis, a condition where one or more of the bones in a baby’s skull close too early, affecting the shape of the head and possibly the development of the brain. The trial aims to gather information about various eye problems that can accompany craniosynostosis, such as difficulties with vision, eye movement, and other related issues. The study will review patient records from those being treated at the Amiens University Hospital.
If you or a family member has been diagnosed with craniosynostosis, you may be eligible to participate in this study. The main requirement is having a confirmed diagnosis of craniosynostosis. Participants will not need to undergo any new treatments; instead, their existing medical records will be analyzed to understand more about the eye conditions associated with this condition. This research could help improve care for future patients by providing insights into the eye health of those with craniosynostosis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of craniostenosis
- Exclusion Criteria:
- • Posterior plagiocephalia
About Centre Hospitalier Universitaire, Amiens
The Centre Hospitalier Universitaire (CHU) Amiens is a leading academic medical center in France dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on multidisciplinary collaboration, CHU Amiens integrates patient care, education, and research to enhance treatment outcomes and improve patient quality of life. The institution is committed to ethical standards and regulatory compliance in its clinical research endeavors, aiming to contribute significantly to the medical community and the development of new therapeutic approaches. By fostering partnerships with various stakeholders, CHU Amiens strives to translate scientific discoveries into practical applications that benefit patients and healthcare systems alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Amiens, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported